Stocktoria
LISATA THERAPEUTICS, INC. LSTA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1995-11-03
LISATA THERAPEUTICS, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $170,000 | $1.0M | $0 | $0 | — |
| R&D expense | — | — | — | — | $17.7M |
| SG&A expense | — | — | $13.0M | $14.1M | $11.5M |
| Operating income | -$18.2M | -$22.4M | -$25.7M | -$57.6M | -$29.1M |
| Income tax | -$962,000 | -$798,000 | -$2.3M | -$2.5M | -$1.5M |
| Net income | -$16.6M | -$20.0M | -$20.8M | -$54.2M | -$27.5M |
| EPS (diluted) | $-1.91 | $-2.40 | $-2.58 | $-10.47 | $-7.45 |
| Operating cash flow | -$15.9M | -$19.4M | -$20.0M | -$21.2M | -$22.2M |
| Free cash flow | -$16.0M | -$19.4M | -$20.0M | -$21.5M | -$22.3M |
| Cash & equivalents | $16.0M | $16.2M | $22.6M | $32.2M | $24.6M |
| Total assets | $17.7M | $35.0M | $54.7M | $73.0M | $97.0M |
| Total liabilities | $3.1M | $5.7M | $6.8M | $6.7M | $5.0M |
| Shareholders' equity | $14.9M | $29.6M | $48.1M | $66.6M | $92.3M |
Source: SEC EDGAR filings · CIK 0000320017 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.